PriceTargets.com logo

Veeva Systems - VEEV Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $257.44
  • Forecasted Upside: 14.85%
  • Number of Analysts: 27
  • Breakdown:
  • 1 Sell Ratings
  • 8 Hold Ratings
  • 18 Buy Ratings
  • 0 Strong Buy Ratings
$224.15 As of 12/20/2024 06:31 PM ET
▲ +4.48 (2.04%)

This chart shows the closing price for VEEV by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Veeva Systems Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VEEV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VEEV

Analyst Price Target is $257.44
▲ +14.85% Upside Potential
This price target is based on 27 analysts offering 12 month price targets for Veeva Systems in the last 3 months. The average price target is $257.44, with a high forecast of $307.00 and a low forecast of $192.00. The average price target represents a 14.85% upside from the last price of $224.15.

This chart shows the closing price for VEEV for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 27 investment analysts is to moderate buy stock in Veeva Systems. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 13 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
6/30/2023
  • 0 strong buy ratings
  • 14 buy ratings
  • 9 hold ratings
  • 1 sell ratings
Ratings as of
9/28/2023
  • 0 strong buy ratings
  • 15 buy ratings
  • 6 hold ratings
  • 1 sell ratings
Ratings as of
12/27/2023
  • 0 strong buy ratings
  • 14 buy ratings
  • 5 hold ratings
  • 1 sell ratings
Ratings as of
3/26/2024
  • 0 strong buy ratings
  • 13 buy ratings
  • 6 hold ratings
  • 1 sell ratings
Ratings as of
6/24/2024
  • 0 strong buy ratings
  • 15 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
9/22/2024
  • 0 strong buy ratings
  • 15 buy ratings
  • 8 hold ratings
  • 1 sell ratings
Ratings as of
11/21/2024
  • 0 strong buy ratings
  • 18 buy ratings
  • 8 hold ratings
  • 1 sell ratings
Ratings as of
12/21/2024

Latest Recommendations

  • 0 strong buy ratings
  • 18 buy ratings
  • 8 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/20/2024StephensInitiated CoverageOverweight$280.00
12/17/2024Morgan StanleyBoost TargetUnderweight ➝ Underweight$183.00 ➝ $195.00
12/16/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$208.00 ➝ $218.00
12/9/2024CitigroupBoost TargetBuy ➝ Buy$281.00 ➝ $307.00
12/6/2024ScotiabankBoost TargetSector Perform ➝ Sector Perform$235.00 ➝ $240.00
12/6/2024BarclaysBoost TargetOverweight ➝ Overweight$260.00 ➝ $275.00
12/6/2024Evercore ISIBoost TargetIn-Line ➝ In-Line$220.00 ➝ $245.00
12/6/2024Bank of AmericaBoost TargetNeutral ➝ Neutral$280.00 ➝ $290.00
12/6/2024Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$275.00 ➝ $285.00
12/6/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$275.00 ➝ $285.00
12/6/2024Stifel NicolausBoost TargetBuy ➝ Buy$240.00 ➝ $272.00
12/6/2024Truist FinancialReiterated RatingHold ➝ Hold$207.00 ➝ $261.00
12/6/2024Canaccord Genuity GroupBoost TargetHold ➝ Hold$210.00 ➝ $270.00
12/6/2024Piper SandlerBoost TargetOverweight ➝ Overweight$280.00 ➝ $290.00
12/6/2024Needham & Company LLCBoost TargetBuy ➝ Buy$260.00 ➝ $270.00
12/6/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$275.00 ➝ $283.00
12/4/2024MizuhoInitiated CoverageOutperform ➝ Outperform$275.00 ➝ $275.00
11/18/2024ScotiabankInitiated CoverageSector Perform$235.00
11/8/2024BarclaysBoost TargetOverweight ➝ Overweight$240.00 ➝ $260.00
11/8/2024Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$250.00 ➝ $275.00
11/8/2024Piper SandlerBoost TargetOverweight ➝ Overweight$230.00 ➝ $280.00
11/8/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$260.00 ➝ $260.00
10/28/2024Robert W. BairdLower TargetOutperform ➝ Outperform$251.00 ➝ $245.00
10/8/2024BNP ParibasInitiated CoverageOutperform$286.00
10/1/2024GuggenheimBoost TargetBuy ➝ Buy$233.00 ➝ $249.00
9/9/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$203.00 ➝ $208.00
9/3/2024Truist FinancialBoost TargetHold ➝ Hold$197.00 ➝ $207.00
8/29/2024TD CowenBoost TargetHold ➝ Hold$180.00 ➝ $192.00
8/29/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$250.00 ➝ $250.00
8/29/2024BarclaysBoost TargetOverweight ➝ Overweight$220.00 ➝ $240.00
8/29/2024Raymond JamesBoost TargetOutperform ➝ Outperform$230.00 ➝ $235.00
8/29/2024Piper SandlerBoost TargetOverweight ➝ Overweight$225.00 ➝ $230.00
8/29/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$260.00 ➝ $260.00
8/29/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$245.00 ➝ $251.00
8/29/2024Bank of AmericaBoost TargetNeutral ➝ Neutral$204.00 ➝ $240.00
8/27/2024CitigroupBoost TargetBuy ➝ Buy$256.00 ➝ $273.00
8/26/2024UBS GroupBoost TargetNeutral ➝ Neutral$185.00 ➝ $215.00
7/18/2024GuggenheimBoost TargetBuy ➝ Buy$211.00 ➝ $233.00
7/15/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$260.00 ➝ $260.00
7/12/2024Piper SandlerLower TargetOverweight ➝ Overweight$235.00 ➝ $225.00
7/9/2024BTIG ResearchInitiated CoverageBuy$240.00
6/21/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$250.00 ➝ $250.00
6/14/2024Truist FinancialLower TargetHold ➝ Hold$203.00 ➝ $197.00
6/3/2024CitigroupLower TargetBuy ➝ Buy$274.00 ➝ $256.00
5/31/2024BarclaysLower TargetOverweight ➝ Overweight$245.00 ➝ $220.00
5/31/2024UBS GroupLower TargetNeutral ➝ Neutral$235.00 ➝ $185.00
5/31/2024Canaccord Genuity GroupLower TargetHold ➝ Hold$220.00 ➝ $210.00
5/31/2024Stifel NicolausLower TargetBuy ➝ Buy$250.00 ➝ $210.00
5/31/2024Evercore ISILower TargetIn-Line ➝ In-Line$230.00 ➝ $200.00
5/31/2024Morgan StanleyLower TargetUnderweight ➝ Underweight$210.00 ➝ $173.00
5/31/2024Piper SandlerLower TargetOverweight ➝ Overweight$245.00 ➝ $235.00
5/31/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$260.00 ➝ $260.00
5/31/2024Bank of AmericaLower TargetNeutral ➝ Neutral$240.00 ➝ $204.00
5/29/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$251.00 ➝ $255.00
4/2/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$260.00
3/27/2024Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$250.00
3/26/2024Raymond JamesReiterated RatingOutperform ➝ Outperform$260.00
3/13/2024JPMorgan Chase & Co.Boost TargetNeutral ➝ Neutral$183.00 ➝ $222.00
3/5/2024KeyCorpBoost TargetOverweight ➝ Overweight$232.00 ➝ $250.00
3/4/2024Jefferies Financial GroupBoost TargetBuy ➝ Buy$225.00 ➝ $270.00
3/1/2024Robert W. BairdBoost TargetOutperform ➝ Outperform$245.00 ➝ $251.00
3/1/2024CitigroupBoost TargetBuy ➝ Buy$240.00 ➝ $264.00
3/1/2024The Goldman Sachs GroupBoost TargetBuy ➝ Buy$219.00 ➝ $248.00
3/1/2024Stifel NicolausBoost TargetBuy ➝ Buy$205.00 ➝ $250.00
3/1/2024Truist FinancialBoost TargetHold ➝ Hold$187.00 ➝ $203.00
3/1/2024Piper SandlerBoost TargetOverweight ➝ Overweight$220.00 ➝ $245.00
3/1/2024BarclaysBoost TargetOverweight ➝ Overweight$240.00 ➝ $245.00
3/1/2024Needham & Company LLCBoost TargetBuy ➝ Buy$220.00 ➝ $260.00
2/26/2024UBS GroupBoost TargetNeutral ➝ Neutral$185.00 ➝ $235.00
2/23/2024BarclaysBoost TargetOverweight ➝ Overweight$220.00 ➝ $240.00
2/22/2024OppenheimerReiterated RatingOutperform ➝ Outperform$225.00
1/24/2024KeyCorpBoost TargetOverweight ➝ Overweight$210.00 ➝ $232.00
1/16/2024Royal Bank of CanadaBoost TargetOutperform ➝ Outperform$225.00 ➝ $250.00
1/2/2024Piper SandlerBoost TargetOverweight ➝ Overweight$200.00 ➝ $220.00
12/8/2023KeyCorpLower TargetOverweight ➝ Overweight$230.00 ➝ $210.00
12/7/2023Stifel NicolausReiterated RatingBuy ➝ Buy$205.00
12/7/2023Canaccord Genuity GroupLower TargetHold ➝ Hold$210.00 ➝ $185.00
12/7/2023Piper SandlerReiterated RatingOverweight ➝ Overweight$200.00
12/7/2023Needham & Company LLCReiterated RatingBuy ➝ Buy$220.00
12/7/2023BarclaysLower TargetOverweight ➝ Overweight$220.00 ➝ $213.00
11/29/2023JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$188.00 ➝ $183.00
11/13/2023Truist FinancialReiterated RatingHold ➝ Hold$227.00
11/13/2023The Goldman Sachs GroupLower TargetBuy ➝ Buy$244.00 ➝ $216.00
11/13/2023Morgan StanleyLower TargetUnderweight ➝ Underweight$181.00 ➝ $160.00
11/10/2023Piper SandlerLower TargetOverweight ➝ Overweight$235.00 ➝ $200.00
11/10/2023Needham & Company LLCReiterated RatingBuy ➝ Buy$220.00
11/10/2023Raymond JamesLower TargetOutperform ➝ Outperform$240.00 ➝ $200.00
10/25/2023Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$211.00 ➝ $229.00
10/13/2023Jefferies Financial GroupInitiated CoverageBuy$265.00
10/11/2023KeyCorpBoost TargetOverweight ➝ Overweight$220.00 ➝ $230.00
9/14/2023Robert W. BairdReiterated RatingOutperform ➝ Outperform$242.00
9/13/2023BarclaysBoost TargetOverweight ➝ Overweight$227.00 ➝ $250.00
9/7/2023Truist FinancialBoost TargetHold ➝ Hold$204.00 ➝ $227.00
9/5/2023Wells Fargo & CompanyBoost TargetEqual Weight ➝ Equal Weight$180.00 ➝ $211.00
8/31/2023Bank of AmericaBoost TargetNeutral ➝ Neutral$200.00 ➝ $220.00
8/31/2023Needham & Company LLCReiterated RatingBuy ➝ Buy$220.00
8/31/2023OppenheimerReiterated RatingOutperform ➝ Outperform$225.00
8/31/2023Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$225.00
8/31/2023Stifel NicolausBoost TargetBuy ➝ Buy$205.00 ➝ $211.00
8/31/2023Canaccord Genuity GroupBoost TargetHold ➝ Hold$170.00 ➝ $210.00
8/31/2023Raymond JamesBoost TargetOutperform ➝ Outperform$210.00 ➝ $240.00
8/31/2023Piper SandlerBoost TargetOverweight ➝ Overweight$232.00 ➝ $235.00
8/31/2023UBS GroupBoost TargetNeutral ➝ Neutral$175.00 ➝ $205.00
8/31/2023Robert W. BairdBoost TargetOutperform ➝ Outperform$235.00 ➝ $242.00
8/31/2023BarclaysBoost TargetOverweight ➝ Overweight$225.00 ➝ $228.00
8/28/2023CitigroupBoost TargetBuy ➝ Buy$210.00 ➝ $236.00
7/31/2023Piper SandlerBoost TargetOverweight$215.00 ➝ $232.00
6/30/2023Robert W. BairdReiterated RatingOutperform ➝ Outperform$235.00
6/28/2023Morgan StanleyDowngradeEqual Weight ➝ Underweight$181.00
6/23/2023BarclaysBoost Target$203.00 ➝ $225.00
6/8/2023Truist FinancialBoost Target$195.00 ➝ $204.00
6/2/2023KeyCorpBoost Target$185.00 ➝ $210.00
6/1/2023Piper SandlerBoost Target$212.00 ➝ $215.00
6/1/2023Raymond JamesBoost Target$200.00 ➝ $210.00
6/1/2023Robert W. BairdBoost Target$227.00 ➝ $235.00
6/1/2023GuggenheimUpgradeNeutral ➝ Buy$226.00
6/1/2023BarclaysBoost Target$197.00 ➝ $203.00
5/31/2023CitigroupLower Target$218.00 ➝ $200.00
5/25/2023KeyCorpLower Target$200.00 ➝ $185.00
5/22/2023UBS GroupLower Target$190.00 ➝ $175.00
3/21/2023OppenheimerReiterated RatingOutperform$225.00
3/17/2023Truist FinancialReiterated RatingBuy ➝ Hold$205.00 ➝ $195.00
3/6/2023TD CowenBoost TargetMarket Perform$184.00 ➝ $189.00
3/3/2023KeyCorpLower TargetOverweight$210.00 ➝ $200.00
3/2/2023Piper SandlerBoost Target$204.00 ➝ $212.00
3/2/2023Truist FinancialLower TargetBuy$225.00 ➝ $205.00
3/2/2023Needham & Company LLCReiterated RatingBuy$220.00
3/2/2023JMP SecuritiesBoost TargetMarket Outperform$215.00 ➝ $230.00
3/2/2023BarclaysLower TargetOverweight$205.00 ➝ $197.00
3/1/2023CitigroupLower TargetBuy$213.00 ➝ $200.00
2/27/2023Robert W. BairdLower TargetOutperform$233.00 ➝ $223.00
2/23/2023GuggenheimDowngradeBuy ➝ Neutral
1/17/2023Raymond JamesLower TargetOutperform$215.00 ➝ $200.00
1/12/2023OppenheimerLower TargetOutperform$250.00 ➝ $225.00
1/9/2023Piper SandlerLower TargetOverweight$220.00 ➝ $204.00
1/6/2023Morgan StanleyLower TargetEqual Weight$190.00 ➝ $181.00
1/4/2023BarclaysUpgradeEqual Weight ➝ Overweight$205.00
12/20/2022UBS GroupLower TargetNeutral$200.00 ➝ $190.00
12/6/2022CowenInitiated CoverageMarket Perform$184.00
12/6/2022CowenInitiated CoverageMarket Perform
12/5/2022KeyCorpLower TargetOverweight$220.00 ➝ $210.00
12/2/2022GuggenheimBoost Target$232.00
12/2/2022Raymond JamesLower TargetOutperform$225.00 ➝ $215.00
12/2/2022Needham & Company LLCBoost TargetBuy$205.00 ➝ $220.00
12/2/2022Leerink PartnersLower TargetOutperform$242.00 ➝ $233.00
11/28/2022UBS GroupBoost TargetNeutral$195.00
10/31/2022Robert W. BairdLower Target$250.00 ➝ $233.00
10/31/2022Wells Fargo & CompanyInitiated CoverageEqual Weight$180.00
10/28/2022The Goldman Sachs GroupLower TargetBuy$235.00 ➝ $205.00
10/20/2022Piper SandlerLower TargetOverweight$245.00 ➝ $220.00
10/19/2022JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$225.00 ➝ $170.00
9/15/2022KeyCorpInitiated CoverageOverweight$220.00
9/6/2022GuggenheimLower Target$230.00
9/6/2022The Goldman Sachs GroupLower Target$235.00
9/1/2022Raymond JamesBoost TargetOutperform$205.00 ➝ $225.00
9/1/2022Canaccord Genuity GroupLower Target$200.00 ➝ $185.00
9/1/2022Royal Bank of CanadaLower TargetOutperform$250.00 ➝ $225.00
9/1/2022Robert W. BairdLower TargetOutperform$267.00 ➝ $250.00
9/1/2022JMP SecuritiesLower TargetMarket Outperform$240.00 ➝ $215.00
9/1/2022UBS GroupLower TargetNeutral$220.00 ➝ $185.00
9/1/2022BarclaysLower TargetEqual Weight$222.00 ➝ $205.00
9/1/2022Piper SandlerLower TargetOverweight$275.00 ➝ $245.00
9/1/2022Leerink PartnersLower TargetOutperform$268.00 ➝ $242.00
8/23/2022BarclaysBoost TargetEqual Weight$195.00 ➝ $222.00
8/16/2022Morgan StanleyBoost TargetEqual Weight$175.00 ➝ $190.00
7/27/2022OppenheimerReiterated RatingInitiates
7/26/2022OppenheimerInitiated CoverageOutperform$250.00
7/18/2022Piper SandlerLower TargetOverweight$290.00 ➝ $275.00
6/29/2022Stifel NicolausBoost TargetBuy$220.00 ➝ $240.00
6/23/2022The Goldman Sachs GroupInitiated CoverageBuy$253.00
6/21/2022GuggenheimReiterated RatingBuy$252.00
6/3/2022CitigroupBoost Target$232.00
6/2/2022Truist FinancialLower TargetBuy$275.00 ➝ $225.00
6/2/2022Canaccord Genuity GroupLower TargetHold ➝ Hold$300.00 ➝ $200.00
6/2/2022Raymond JamesLower Target$260.00 ➝ $205.00
6/2/2022JMP SecuritiesLower TargetMarket Outperform$265.00 ➝ $240.00
6/2/2022Needham & Company LLCLower TargetBuy$270.00 ➝ $205.00
5/24/2022BarclaysLower TargetEqual Weight$237.00 ➝ $195.00
3/14/2022Leerink PartnersReiterated RatingBuy$268.00
3/10/2022JMP SecuritiesLower TargetMarket Outperform$345.00 ➝ $265.00
3/3/2022Leerink PartnersLower TargetOutperform$282.00 ➝ $268.00
3/3/2022GuggenheimLower TargetBuy$350.00 ➝ $255.00
3/3/2022Bank of AmericaDowngradeBuy ➝ Neutral$300.00 ➝ $220.00
3/3/2022Needham & Company LLCLower TargetBuy$327.00 ➝ $270.00
3/3/2022Robert W. BairdLower Target$303.00 ➝ $288.00
3/3/2022Raymond JamesLower TargetOutperform$335.00 ➝ $260.00
3/3/2022Royal Bank of CanadaLower TargetOutperform$400.00 ➝ $300.00
3/3/2022Piper SandlerLower TargetOverweight$300.00 ➝ $290.00
3/1/2022CitigroupLower Target$349.00 ➝ $278.00
2/28/2022BarclaysLower TargetEqual Weight$310.00 ➝ $260.00
1/28/2022Truist FinancialInitiated CoverageBuy$275.00
1/10/2022Piper SandlerLower Target$360.00 ➝ $300.00
1/7/2022StephensDowngradeOverweight ➝ Equal Weight$275.00
1/6/2022Leerink PartnersUpgradeMarket Perform ➝ Outperform$282.00
12/16/2021Morgan StanleyDowngradeOverweight ➝ Equal Weight$330.00 ➝ $280.00
12/13/2021CitigroupLower TargetBuy ➝ Buy$356.00 ➝ $349.00
12/2/2021Needham & Company LLCLower TargetBuy$385.00 ➝ $327.00
12/2/2021Robert W. BairdLower TargetOutperform$349.00 ➝ $310.00
12/2/2021UBS GroupLower TargetIn-Line ➝ Neutral$320.00 ➝ $290.00
12/2/2021Leerink PartnersLower TargetMarket Perform$296.00 ➝ $282.00
10/20/2021William BlairReiterated RatingBuy
10/1/2021Stifel NicolausInitiated CoverageBuy$335.00
9/2/2021Robert W. BairdBoost TargetOutperform$340.00 ➝ $349.00
9/2/2021Bank of AmericaBoost TargetBuy$340.00 ➝ $350.00
9/2/2021JMP SecuritiesBoost TargetPositive ➝ Outperform$320.00 ➝ $345.00
9/2/2021UBS GroupBoost TargetNeutral$270.00 ➝ $320.00
9/2/2021Needham & Company LLCBoost TargetBuy$336.00 ➝ $385.00
9/2/2021Leerink PartnersBoost TargetMarket Perform$294.00 ➝ $296.00
9/2/2021CitigroupBoost TargetBuy$340.00 ➝ $356.00
8/31/2021GuggenheimReiterated RatingBuy
7/21/2021CowenInitiated CoverageOutperform$400.00
7/21/2021Royal Bank of CanadaInitiated CoverageOutperform$400.00
5/28/2021Piper SandlerBoost TargetOverweight$350.00 ➝ $360.00
5/28/2021Morgan StanleyBoost TargetOverweight$340.00 ➝ $350.00
5/28/2021BarclaysBoost TargetEqual Weight$310.00 ➝ $320.00
5/28/2021CitigroupBoost TargetBuy$335.00 ➝ $340.00
3/31/2021Raymond JamesReiterated RatingBuy
3/31/2021UBS GroupUpgradeSell ➝ Neutral$245.00 ➝ $250.00
3/4/2021CitigroupBoost TargetBuy$320.00 ➝ $335.00
3/3/2021Truist FinancialBoost Target$320.00 ➝ $355.00
3/3/2021DA DavidsonBoost Target$325.00 ➝ $350.00
3/3/2021Morgan StanleyBoost TargetOverweight$332.00 ➝ $340.00
3/3/2021Needham & Company LLCBoost TargetBuy$327.00 ➝ $336.00
3/3/2021Leerink PartnersBoost TargetMarket Perform$282.00 ➝ $294.00
3/3/2021Piper SandlerBoost TargetOverweight$340.00 ➝ $350.00
2/17/2021KeyCorpBoost TargetOverweight$332.00 ➝ $353.00
1/11/2021Piper SandlerBoost Target$310.00 ➝ $340.00
1/7/2021KeyCorpInitiated CoverageOverweight$332.00
12/9/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$297.00
12/2/2020DA DavidsonReiterated RatingBuy
12/2/2020Morgan StanleyBoost TargetOverweight$323.00 ➝ $332.00
12/2/2020JMP SecuritiesBoost TargetPositive ➝ Outperform$293.00 ➝ $305.00
12/2/2020Needham & Company LLCBoost TargetBuy$310.00 ➝ $327.00
10/26/2020Raymond JamesBoost TargetOutperform$285.00 ➝ $335.00
10/13/2020UBS GroupInitiated CoverageSell$225.00
8/31/2020Morgan StanleyBoost TargetOverweight$253.00 ➝ $323.00
8/28/2020FBN SecuritiesBoost TargetPositive ➝ Outperform$300.00 ➝ $310.00
8/28/2020Truist FinancialBoost Target$222.00 ➝ $320.00
8/28/2020JMP SecuritiesBoost Target$210.00 ➝ $293.00
8/28/2020JPMorgan Chase & Co.Boost TargetNeutral$200.00 ➝ $297.00
8/28/2020Bank of AmericaBoost TargetBuy$230.00 ➝ $302.00
8/28/2020DA DavidsonBoost TargetBuy$235.00 ➝ $325.00
8/28/2020Stifel NicolausBoost TargetBuy$225.00 ➝ $300.00
8/28/2020Leerink PartnersBoost TargetMarket Perform$167.00 ➝ $282.00
8/28/2020Raymond JamesBoost TargetOutperform$230.00 ➝ $285.00
8/28/2020Needham & Company LLCBoost TargetPositive ➝ Buy$235.00 ➝ $310.00
8/28/2020StephensBoost TargetOverweight$290.00 ➝ $325.00
8/28/2020Piper SandlerBoost TargetOverweight$220.00 ➝ $310.00
8/26/2020BarclaysBoost TargetEqual Weight$200.00 ➝ $261.00
8/20/2020GuggenheimBoost TargetBuy$225.00 ➝ $300.00
8/14/2020Morgan StanleyBoost TargetOverweight$230.00 ➝ $253.00
7/23/2020FBN SecuritiesInitiated CoverageOutperform$300.00
7/6/2020StephensInitiated CoverageOverweight$290.00
6/29/2020The Goldman Sachs GroupBoost Target$197.00 ➝ $228.00
6/22/2020Robert W. BairdBoost TargetOutperform$242.00 ➝ $256.00
6/8/2020Needham & Company LLCInitiated CoverageBuy$235.00
6/8/2020CitigroupInitiated CoverageBuy$265.00
6/1/2020William BlairReiterated RatingBuy
5/29/2020CfraBoost TargetHold$164.00 ➝ $208.00
5/29/2020SunTrust BanksBoost Target$167.00 ➝ $222.00
5/29/2020Raymond JamesReiterated RatingOutperform$180.00 ➝ $230.00
5/29/2020DA DavidsonBoost TargetBuy$200.00 ➝ $235.00
5/29/2020Morgan StanleyBoost TargetOverweight$226.00 ➝ $230.00
5/29/2020Needham & Company LLCBoost TargetBuy$187.00 ➝ $235.00
5/29/2020Leerink PartnersBoost TargetMarket Perform$166.00 ➝ $167.00
5/29/2020Piper SandlerBoost TargetOverweight$180.00 ➝ $220.00
5/27/2020BarclaysBoost TargetEqual Weight$176.00 ➝ $200.00
5/22/2020Morgan StanleyBoost TargetOverweight$175.00 ➝ $226.00
4/13/2020Leerink PartnersInitiated CoverageMarket Perform$166.00
4/13/2020Needham & Company LLCReiterated RatingBuy$187.00
3/31/2020Piper SandlerLower TargetOverweight$188.00 ➝ $180.00
3/26/2020SunTrust BanksLower TargetBuy$175.00 ➝ $167.00
3/25/2020Morgan StanleyLower TargetOverweight$176.00 ➝ $175.00
3/4/2020CfraLower TargetHold$185.00 ➝ $164.00
3/4/2020Robert W. BairdBoost TargetOutperform$184.00 ➝ $190.00
3/4/2020Bank of AmericaReiterated RatingBuy$192.00 ➝ $180.00
3/4/2020Stifel NicolausLower TargetBuy$185.00 ➝ $170.00
3/4/2020Morgan StanleyBoost TargetOverweight$175.00 ➝ $176.00
2/18/2020Robert W. BairdInitiated CoverageOutperform$184.00
2/14/2020Piper SandlerInitiated CoverageOverweight$188.00
1/13/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$160.00 ➝ $175.00
1/7/2020Deutsche Bank AktiengesellschaftLower TargetHold$160.00 ➝ $150.00
(Data available from 12/21/2019 forward)

News Sentiment Rating

1.17 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 32 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/25/2024
  • 30 very positive mentions
  • 10 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
6/24/2024
  • 19 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/24/2024
  • 22 very positive mentions
  • 14 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
8/23/2024
  • 44 very positive mentions
  • 35 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2024
  • 30 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2024
  • 40 very positive mentions
  • 36 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2024
  • 82 very positive mentions
  • 34 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2024

Current Sentiment

  • 82 very positive mentions
  • 34 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Veeva Systems logo
Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process. In addition, it offers professional and support services, including implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; data migration and systems integrations technical consulting services; training on its solutions; and ongoing managed services, such as outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
Read More

Today's Range

Now: $224.15
Low: $218.44
High: $227.10

50 Day Range

MA: $222.99
Low: $208.78
High: $250.45

52 Week Range

Now: $224.15
Low: $170.25
High: $258.93

Volume

2,374,109 shs

Average Volume

995,934 shs

Market Capitalization

$36.39 billion

P/E Ratio

55.35

Dividend Yield

N/A

Beta

0.82

Frequently Asked Questions

What sell-side analysts currently cover shares of Veeva Systems?

The following Wall Street sell-side analysts have issued stock ratings on Veeva Systems in the last year: Bank of America Co., Barclays PLC, BNP Paribas, BTIG Research, Canaccord Genuity Group Inc., Citigroup Inc., Evercore ISI, Guggenheim, Jefferies Financial Group Inc., JPMorgan Chase & Co., KeyCorp, Mizuho, Morgan Stanley, Needham & Company LLC, Oppenheimer Holdings Inc., Piper Sandler, Raymond James, Robert W. Baird, Royal Bank of Canada, Scotiabank, Stephens, Stifel Nicolaus, StockNews.com, TD Cowen, The Goldman Sachs Group, Inc., Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for VEEV.

What is the current price target for Veeva Systems?

0 Wall Street analysts have set twelve-month price targets for Veeva Systems in the last year. Their average twelve-month price target is $257.44, suggesting a possible upside of 14.9%. Citigroup Inc. has the highest price target set, predicting VEEV will reach $307.00 in the next twelve months. TD Cowen has the lowest price target set, forecasting a price of $192.00 for Veeva Systems in the next year.
View the latest price targets for VEEV.

What is the current consensus analyst rating for Veeva Systems?

Veeva Systems currently has 1 sell rating, 8 hold ratings and 18 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for VEEV.

What other companies compete with Veeva Systems?

Other companies that are similar to Veeva Systems include AppLovin, Infosys, CrowdStrike, Atlassian and Trade Desk. Learn More about companies similar to Veeva Systems.

How do I contact Veeva Systems' investor relations team?

Veeva Systems' physical mailing address is 4280 HACIENDA DRIVE, PLEASANTON CA, 94588. The technology company's listed phone number is (925) 452-6500 and its investor relations email address is [email protected]. The official website for Veeva Systems is www.veeva.com. Learn More about contacing Veeva Systems investor relations.